Skip to main content
. 2021 Jan 6;16(1):12–37. doi: 10.1007/s11481-020-09968-x

Fig. 3.

Fig. 3

Current vaccine strategies for SARS-CoV-2. Clockwise from top left: (a), delivery of mRNA encoding viral protein through lipid nanoparticle; (b), direct delivery(electroporation) of plasmid DNA encoding viral protein; (c), human and chimpanzee adenovirus-based delivery of DNA encoding viral protein; (d), injection of inactivated viral vector; (e), injection of genetically modified immune cells